Clinical Trial Update: Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating HS-25 alone or in combination with atorvastatin in Chinese adults with primary hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• HS-25
• atorvastatin (atorvastatin)

Snippet

Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd. | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: UNKNOWN